Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,567
-$9,278 QoQ
Shares Held
10
-85.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,595
of 1,603 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Operose Advisors LLC holds $4,264,256 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,615 | $1,161,318 | |
| 2 | LLY |
ELI LILLY & Co
|
842 | $1,009,920 | |
| 3 | JNJ |
Johnson & Johnson
|
2,741 | $696,131 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,872 | $626,052 | |
| 5 | PFE |
Pfizer Inc
|
25,400 | $611,632 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
800 | $101,072 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
500 | $28,810 | |
| 8 | AMGN |
Amgen Inc
|
73 | $26,434 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,567 | 10 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,845 | 71 | Shares | Sole | 2026-05-12 | |
| 2024-09-30 | $32,090 | 279 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,702 | 279 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $26,987 | 279 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $28,170 | 279 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $28,418 | 279 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||